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Abstract 
 
This work explores the factors that spur firms’ propensity to enter in international markets. 
Among the whole population of Spanish firms active in the pharmaceutical sector (over the period 
1995-2004), we identify those firms that have entered the US market by assessing whether they 
have filed at least a trademark in the US Patents and Trademarks Office.  By means of a hazard 
model, we empirically estimate which firm’s characteristics affect the probability of entry in the 
US market in a given year. Results show that technological capabilities (breadth and depth of 
firms’ patent base), and the firm’s cost structure explain the entry in the US market with a branded 
product. Moreover, our evidence shows that entry strategies based on differentiation advantage 
(technological diversification) and strategies based on cost advantage (scale economies) are 
exclusive and do not mix well each other. 
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1. Introduction 
Firms that are able to access international markets not only are in the position of gaining 
higher profits but they also have the chance to reduce the firm’s market risk by averaging 
complementary economic trends in different countries. Moreover, imitation of international 
leaders and the participation into a global network of knowledge creation allow the firm to 
increase its knowledge base with beneficial increasing returns in learning. Especially in 
knowledge based industries, the firm internationalization propensity is pivotal. 
Nevertheless, not all the firms succeed in entering foreign markets. This work 
investigates which firms’ characteristics increase the internationalization propensity in a 
global high-tech market such as the pharmaceuticals. The choice of the pharmaceutical 
industry represents a natural test bed for our hypotheses. Not only the pharmaceutical 
industry is a very internationalized, global industry, but it also shows a higher propensity 
than other industries to disperse innovative activity across borders (Pearce, 1989; McKelvey 
et al., 2004). Furthermore, the features of the industry structure – characterized by few very 
large global companies, and a myriad of SMEs often acting as licensees of major leaders – 
reveals that cost factors and the possibility to exploit economies of scale determine the 
distribution of the competitive advantage across firms. Therefore, it is exactly in contexts like 
that of the pharmaceutical industry that the role of firms’ technological capabilities and cost 
structure can be analyzed. 
We focus on the whole population of Spanish firms active in the pharmaceutical sector, 
and we identify those that have entered the US market with a branded product. More 
specifically, for each firm we test the significance of factors like breadth and depth of firms’ 
technological base (patent portfolio), and firms’ cost structure. Our evidence shows that 
firms with higher diversified patent portfolios and that benefit of more intense cost 
efficiency show a higher probability of entry in a foreign market. Interestingly, we also 
analyze how the interaction between the two factors affects firms’ entry decision, and we 
show that firms facing strong cost disadvantages can still increase their probability of entry 
by opting for a patent concentration strategy. 
Our work proposes these claims on novelty. We propose a novel measure of 
internationalization, which is derived the analysis of trademarks filed at the US Patent and 
Trademark Office. For several reasons, this proxy is more flexible than traditional 
internationalization measures. It allows us to track not only internationalization strategies 
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based on the classical opening of a foreign subsidiary, but also lighter forms of international 
strategies based only on market penetration. In turn, our internationalization measure does 
not depend on the organizational form adopted to achieve such a goal. 
Furthermore, we confirm that strategies pursuing technological diversification and cost 
advantage are basic to understand the international propensity in high tech markets. 
Moreover, we study the not linear relationship existing between the two. 
The remaining of the paper is organized as follows. The next section focuses on the 
review of previous literature and formulates our main hypotheses. In Section 3 we describe 
the database used for the analysis and introduce the empirical methodology. In Section 4 we 
introduce the empirical analysis and present our main econometric results. Finally, Section 5 
concludes. 
 
2. Literature review and hypotheses 
In studying firms’ foreign market entry decisions, the economic and managerial literature 
has traditionally paid attention to two broad, interdependent issues. The first one concerns 
the means by which firms choose to operate in a particular market – that is the mode of 
entry (Woodcock et al., 1994; Madhok, 1997; Mascarenhas, 1997). The second relevant issue 
is the analysis of motivations that induce firms to enter a foreign market. According to this 
stream of literature, firms decide to enter a particular market either to exploit or to 
strengthen an advantage they already possess, or to create and develop a new one. The 
eclectic paradigm of international production sustains this approach (Dunning, 1993, 1997, 
2000). 
As stated by the eclectic paradigm, the propensity of a firm to engage in international 
expansion is strictly linked to the possession of one or more types of advantages, namely 
ownership, internalization, and localization advantages. We focus our attention on the 
ownership advantage (Lieberman and Montgomery, 1998; Narula, 1996; Narula and 
Dunning, 2000). Empirical evidence supports this view (Agarwal and Ramaswami, 1992; 
Makino et al., 2002). 
Therefore, the ability to internationalize and succeed in foreign markets is a function of 
the internal capabilities of the firm (Autio et al., 2000; Zahra et al., 2000). Under this 
perspective, firms with superior capabilities create new knowledge that leads to the 
development of critical organizational capabilities and embedded routines. These 
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organizational capabilities could refer to the ability of achieving a production function of 
greater efficiency or to improved technological capabilities. Both could provide superior 
performance in the entry into foreign markets. 
Thus, among internal capabilities that shape a firm’s ownership advantage, we draw 
upon existing literature to identify three types of factors that have been shown to have 
effects on firms’ internationalization decisions: innovative capabilities, scope economies, 
and cost efficiency. Below, we develop a set of hypotheses that link these factors to the 
probability of entry into foreign markets. 
 
2.1 Innovative capabilities 
Technological resources play a double role in driving a firm’s multinational expansion (Tseng 
et al., 2007). On the one hand, firms move abroad to better exploit technologies developed 
in the home country. Indeed, technological resources can be replicated among several 
geographical markets without incurring the full costs of their development. In so doing, the 
firm gains the so-called “location specific advantage” (Dunning, 1993). Given the high fixed 
costs in R&D, international expansion increases the size of the final market of a R&D 
investment, fostering efficiency. On the other hand, firms involved in new foreign markets 
have to learn and adapt their product according to different customers’ tastes. In this 
respect, a firm with stronger technological resources acquires a higher absorptive capacity of 
local knowledge (Cohen and Levinthal, 1990), and is placed in a better position to quickly 
respond to local feedbacks. 
In one of the first studies that analyzed the relation between exports and innovation, 
Hirsch and Bijaoui (1985) considered the relationship between R&D expenditures and export 
behaviour for Israeli firms. They found that innovation confers some monopoly power to the 
owner of the innovation. As a result, the firm discriminates between the domestic and 
foreign markets. This is not true for non-innovating firms that are assumed to be price takers 
and, hence, have less incentive to export. In their empirical study, they found that innovating 
firms in a sector have a higher propensity to export than the sector average, and that lagged 
R&D expenditure is significant in explaining the rate of change of exports in a cross-section 
analysis. 
Several papers have followed this line of research confirming the relation between 
innovation and export. Sterlacchini (1999) argues that a broader definition of innovation is 
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necessary to capture the full effect on exports. Even in non-R&D intensive industries 
innovation is an important determinant of small firm’s export performance. Including the 
acquisition of innovative capital goods and design, engineering and pre-production 
development has been found to be relatively more important for these firms. Lefebvre et al. 
(1998), and Becchetti and Rossi (2000) both found that R&D intensity has no impact on the 
export propensity, but that other innovation indicators such as the percentage of employees 
with technical and scientific backgrounds and the presence of R&D collaborations with 
external partners have positive effects. Furthermore, Brouwer and Kleinknecht (1993) found 
a positive effect of R&D on export activity, but they emphasized that it is product – as 
opposed to total – R&D that is relevant for this effect. Similarly, Bernard and Jensen (1999, 
2004) found that, for a large sample of American manufacturing plants, the introduction of 
new products significantly enhances the probability of exporting. In sum, we hypothesize: 
 
Hypothesis 1. The stronger a firm’s innovative capabilities, the higher the likelihood of entry 
in foreign markets with branded products. 
 
2.2 Scope economies 
Scope economies have been already recognized to be a determinant of early entry in foreign 
markets (Gaba et al., 2002). Indeed, firms with a broader product portfolio can profit from 
potential synergies among market segments and benefit of a wider possibility of choosing 
the most appropriate combination for the host country. Thus, scope economies allow firms 
to gain a differentiation competitive advantage (Porter, 1985), and to exploit that advantage 
in the foreign market (Kimura, 1989). 
In innovation-based markets, in order to implement a differentiation strategy, firms 
need to possess superior competencies on a broader range of technological fields such to 
develop products better suited to the characteristics of the (new) market, thus reducing the 
risk of entering into it and increasing the ability to learn from it. Consequently, the breadth 
of a firm’s product line is often associated to the breadth of the firm’s technological 
portfolio. Therefore, technological diversification can be leveraged in the international arena 
in order to effectively exploit the firm’s scope economies. The extension of activities into 
new fields of production and across a variety of geographical sites allows the firm to take 
advantage of and consolidate existing technological capabilities (Cantwell, 1995). In turn, 
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corporate internationalization and the diversification of technological activities are both 
ways of spreading the competence base of the firm and of acquiring new technological 
assets or sources of competitive advantage (Cantwell and Janne, 1999; Cantwell and 
Piscitello, 2000, 2002). 
In a recent paper, Quintana-García and Benavides-Velasco (2008) show that, in a sample 
of US biotechnology firms, the magnitude of technological diversification is directly and 
positively associated to both exploitative and explorative innovative competences of firms. 
According to the authors, this empirical evidence suggests that a broader technological base 
helps firms in overcoming potential core rigidities and path dependencies, thus enhancing 
their capability to develop innovative solutions, especially towards directions unrelated to 
the firms’ past activities. We argue that this greater innovative capability in diversified 
technological areas also helps firms in overcoming the difficulties related to processes of 
international expansion. Technologically diversified companies have more strategic options 
needed to face more complex international scenarios that, in different sectors and places, 
can offer different opportunities and limitations. They can benefit of a larger portfolio of 
technological competences that permit an effective utilization of new knowledge and a 
prompt commercial exploitation of technological opportunities in the moment and in the 
place in which such opportunities arise. Thus, we hypothesize: 
 
Hypothesis 2. The higher the diversification of a firm’s technological portfolio (scope 
economies), the higher the likelihood of entry in foreign markets with branded products. 
 
2.3 Cost efficiency 
Apart from leveraging economies of scope in order to create a differentiation advantage, 
firms may pursue the alternative competitive strategy of cost efficiency (Porter, 1985). By 
using a cost efficiency strategy, companies compete with a standard, low cost product, since 
they maintain the cost structure to a certain threshold acceptable to cover the level of 
variable costs. 
The cost structure also influences firms’ internationalization decisions and possibilities. 
A firm deciding to enter into a new international market by means of a cost efficiency 
strategy should constrain its average cost of production in order to be competitive and thus 
gaining competitive advantage in the new market. Economies of scale are seen as one of the 
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fastest avenues to build a competitive advantage. Cost advantage could be used to increase 
the flexibility in implementing a price strategy, by reducing and augmenting price margins 
according to the level of competition. This could substantially help firms that aim to 
penetrate international markets: the higher the flexibility in moving the product price, the 
higher the bargaining power with local distributors and the lower the perceived risk. 
The empirical evidence supports the existing relationship between a firm’s cost 
structure and internationalization. For instance, Wakelin (1998) finds that cost 
considerations play some role in the firms’ export performance, especially for the non-
innovating firms. Indeed, higher cost firms show a lower propensity of engaging in exporting 
activity. Similarly, Basile (2001) empirically demonstrate that the level of unit labor cost 
represents a measure of a firm’s cost/price competitiveness, which negatively affects 
exports in cost sensitive export markets. Thus, in his sample of Italian manufacturing firms, 
firms with higher labor costs per unit of product are less likely to enter foreign markets. 
Based on these considerations, we hypothesize: 
 
Hypothesis 3. The higher the level of a firm’s cost efficiency, the higher the likelihood of entry 
in foreign markets with branded products. 
 
2.4 Interaction between cost efficiency and scope economies 
It is worth noting that the traditional theoretical approach on competitive strategies 
suggests that the intrinsic nature of cost leadership and differentiation strategies is such that 
the two alternatives cannot be pursued and implemented simultaneously (Porter, 1985). In 
the case of firms involved in exporting, the empirical evidence seems to suggest that, under 
certain circumstances, a pure competitive strategy is preferred over other strategic 
alternatives. For example, Namiki (1988) finds that among firms competing in export 
markets those following a single strategy – i.e., either differentiation focus or innovative 
differentiation – show the higher performance. Aulakh et al. (2000) posit that the 
simultaneous use of both cost leadership and differentiation strategies is negatively related 
to their export performance. Similarly, Salavou and Halikias (2009) show that the hybrid 
form of competitive advantage pursued by exporting firms, although dominant, does not 
offer the most profitable strategic choice. 
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The issue of whether a pure competitive strategy yields to a higher performance with 
respect to a hybrid strategy has been debated for long, often with contrasting results 
(among others, see Dess and Davis, 1984; Nayyar, 1993; Spanos et al., 2004; Wu et al., 
2007). 
Similarly to situations in which firms need to combine both explorative and exploitative 
innovative activities, hybrid strategies can be pursued by ambidextrous organizations 
(Tushman and O’Reilly, 1996), which are able to join together the search for greater 
efficiency – typical of exploitation – with the search for variation and new solutions – typical 
of exploration. If these apparently irreconcilable activities can be effectively integrated by 
firms within the same organizational unit, a higher performance is expected (Raisch et al., 
2009; Andriopoulos and Lewis, 2009).. 
Thus, ambidextrous organizations – which are capable of simultaneous exploitation of 
current competencies and exploration of new domains – are expected to be better able to 
pursue hybrid competitive strategies based on the simultaneous deployment of both cost 
leadership and differentiation advantages. In turn, this organizational capability is expected 
to bring a higher internationalization performance. Nevertheless, the integration of 
exploration and exploitation activities is a complex task for organizations that demands 
managerial experience and effort. Such integrative efforts may strain firms and reduce the 
performance potential (Gibson and Birkinshaw, 2004).  As a consequence, we hypothesize: 
 
Hypothesis 4. The simultaneous exploitation of cost efficiency (cost advantage) and of scope 
economies (differentiation advantage) increases the likelihood of entry in foreign markets. 
 
3. Empirical strategy 
3.1 Sample 
This study is based on a database that has been built by the match between several sources 
of information. First, we selected from the SABI dataset the sample of Spanish firms 
classified under the industrial activity “Manufacturing of Pharmaceutical Products”.
1
 We 
focused on the period 1995-2004, and we ended up with 507 firms. We used the SABI 
                                                           
1
 The SABI database (Bureau van Dijk Electronic Publishing) reports financial information on more than one million Spanish 
firms and more than 300.000 Portuguese firms. Firms are classified according to the Spanish National Classification of 
Economic Activities (CNAE). The “Manufacturing of Pharmaceutical Products” class corresponds to CNAE code n. 244. 
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dataset to draw information on the financial (e.g., sales, costs, profits, fixed assets, 
profitability) and structural characteristics (age, size, legal type) of our sample companies. 
Second, we matched this list of Spanish pharmaceutical firms with the list of owners of 
patents registered at the European Patent Office, in order to collect information on the 
patent portfolio of our sample companies. We found 40 firms having filed at least one 
patent in the European Patent Office. 
Third, we verified whether our sample firms are independent legal entities or whether 
they belong to industrial groups, by using the 1998 version the of Who Owns Whom 
database.
2
 We were able to identify 139 firms being not independent in 1998. Furthermore, 
we identified those firms having at least a subsidiary in the US (only two firms), and those 
whose parent company is a firm located in the US (18 cases in total). 
Finally, we searched the trademark database of the US Patent and Trademark Office 
(www.uspto.gov) for trademarks registered by our sample companies. We discovered 21 
firms having filed at least one trademark during the same time period (see Table 1). As 
explained below, we use such information to determine the time of entry of our sample 
companies into the US market. Given that our main purpose is to study the determinants of 
entry into that foreign market, we are only interested in analyzing the characteristics and 
behavior of our firms before the entry. Therefore, we did not take into account neither the 
total number of trademarks owned by a company, nor the characteristics of the same 
company after the year of entry into the US market. 
According to the sampling procedure that we adopted, our final sample consists of an 
unbalanced panel of 507 firms over a period of 10 years (4,961 observations in total). 
 
TABLE 1 ABOUT HERE 
 
3.2 Measurement of variables 
Dependent variable. 
Internationalization strategies can be pursued through two (not necessarily alternative) 
entry modes: exporting and foreign production. Then, each of them can be implemented by 
means of several forms that go from the use of international trading companies, to the 
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settlement of product licensing contracts with local manufacturers, to direct investments. 
Each entry mode affects the amount of investments required, and therefore the associated 
level or risk – indirect exporting can be viewed as the most conservative and least risky entry 
mode, while Foreign Direct Investments require the highest level of investments and imply 
the highest risk for firms. Figure 1 offers a representation of such alternatives. 
  
FIGURE 1 ABOUT HERE 
 
According to the distinction between exporting and foreign production as potential 
entry modes, previous studies on firms’ internationalization processes have used as outcome 
measure either a firm’s level of export (mainly in terms of export intensity, i.e. exports as a 
share of total firm’s sales), or the amount of a firm’s investments in production facilities 
located abroad. In this study, we follow an alternative, innovative approach and we make 
use of trademarks as an objective indicator of entry into the foreign market with a branded 
product. 
As Mendonça et. al (2004) argued, trademarks play a crucial role in marketing 
innovations, being instrumental in differentiating the attributes of goods and services in the 
marketplace. In turn, our internationalization strategy does not depend on the 
organizational form adopted to achieve such a goal. This entry mode, however, requires the 
firm to possess some absorptive capacity to diffuse its knowledge to other foreign markets 
and to be cost efficient. 
Trademarks can be considered as an objective measure of active presence of a firm in a 
market because, i) “a trademark includes any word, name, symbol, or device, or any 
combination, used, or intended to be used, in commerce to identify and distinguish the 
goods of one manufacturer or seller from goods manufactured or sold by others, and to 
indicate the source of the goods”,
3
 and ii) that a requirement for a trademark property right 
to emerge is that the mark must be actively used in the market otherwise is cancelled
4
. That 
                                                                                                                                                                                     
2
 Who Owns Whom (published by Dun & Bradstreet, Inc.) is a worldwide directory that links a company to its corporate 
family. The dataset reports information concerning the corporate structure, family hierarchy, and few information on the 
parent company, headquarters, branches, and subsidiaries worldwide. 
3
 From the USPTO web page: http://www.uspto.gov/web/offices/tac/tmfaq.htm#DefineTrademark. Last assessed: July 
15th, 2009. 
4
 Failure to actively use a trademark for a certain period of time (five years in the US) will result in abandonment of the 
mark, which will then be part of the public domain. Abandonment of the mark determines cessation of the trademark 
property right. 
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is, if a firm owns any trademark in a specific market – the US market, in the specific context 
of this study – it means that that firm has entered the market at least with the weakest 
form. Obviously, because a trademark only signals the active presence of a firm in a market, 
it does not provide any information on the details of the firm’s presence. 
Trademarks are important to protect the firm brand from imitation. Brand names 
reduce search costs for buyers who cannot observe ex-ante the quality of the product or 
service and therefore serve the function of identifying the provider of a good by making a 
name visible in the marketplace (Schmoch, 2003). This suggests that the date of the first 
trademark registered by a foreign firm in the trademark office signals the first step of its 
entry process with a branded product or service. 
It is worth noting that trademarks imply direct monetary and indirect administrative 
costs – the owner must file a trademark application for each class of goods/services, pay 
application fees and renewal fees, file a statement of use, demonstrate that it uses the mark 
in commerce and file requests for time extension. At regular intervals, the owner has to 
demonstrate that it has used the mark in commerce for five consecutive years and pay 
extension fees. Maintenance costs include attorney fees.  
In order to collect information on trademarks, we searched in the US trademark 
database at USPTO (www.uspto.gov) for trademarks registered by our sample companies. 
Then, we considered the year when the firm filed its first trademark as the year of entry in 
the US market. So, we were able to construct a dependent variable (ENTRY) that takes the 
value 1 if the firm has entered the US market in a specific year and 0 otherwise. During the 
period under study (1995-2004), 21 sample firms entered the US market with a branded 
product. 
 
Core variables of theoretical interest 
We built two patent-based variables. The first, TECH_CAPABILITIES, is the time-variant stock of 
firm patents filed at the European Patent Office during the sample period, divided by the 
sales of the company during the same period of time. This measure can be considered a 
proxy for the overall innovative capabilities of the company, given its size. 
The second, SCOPE_ECONOMIES, has been built by computing the Herfindhal index of the 
different technological patent classes in which the sample firms own patents. The first two 
digits of the main IPC technological class have been used. Provided that the Herfindhal index 
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is a measure of concentration, the higher the value of the index, the higher the degree of 
concentration of the company’s patent portfolio, that is, the lower the firm’s degree of 
technological diversification. 
It is worth noting that the use of patents as an indicator of advanced technological 
capacity and ability to develop innovations is one of the most established and reliable 
methods of estimating the patterns of innovative activities. The advantages and 
disadvantages of using patent statistics are well known in the literature (Schmookler, 1966; 
Pavitt, 1985; Griliches, 1990). 
As far as firm’s cost efficiency measure is concerned, we built the variable INV_EFFICIENCY 
by dividing the yearly amount of a firm’s production costs (variable costs) plus investments 
in long-term tangible assets (fixed costs), by the firm’s volume of sales. This measure 
represents an approximation of a firm’s average cost in a given year, and therefore it is 
inversely related to the firm’s level of production efficiency. Notice that, the lower the level 
of INV_EFFICIENCY, the lower the firm’s average cost, the higher the firm’s cost efficiency. 
 
Control variables 
We included several controls in our analysis. As a control for firm size we used the firm’s 
amount of fixed assets (FIXED_ASSET). Then, we introduced the firm’s age, calculated as the 
difference between the year of firm foundation and each year of the sample period (AGE). 
We also took into account the firm’s profitability by including the level of Return on Assets 
(ROA), which assesses the firm’s ability to generate financial resources that might be used 
for the firm’s plans of multinational expansion (Tseng et al., 2007).  
Moreover, in order to take into account the influence of the legal form on the firm’s 
policies and actions (e.g., the possibility to raise additional financial resources in the stock 
market), we included the dummy time invariant variable CORPORATION, which takes the value 
1 in the case the firm opted for a “Sociedad Anonima” legal form. 
Similarly, we included few variables related to the firm’s group structure. GROUP_98 is a 
dummy variable that takes the value 1 if the firm was part of an industrial group  in 1998, 
and 0 otherwise. PARENT_US is a dummy variable that takes the value 1 if the firm’s parent 
company has its headquarter in the US, and 0 otherwise. SUBSIDIARY_US is a dummy variable 
that takes the value 1 if the firm has at least a subsidiary whose headquarter is located in the 
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US, and 0 otherwise. Finally, we included the yearly values of Dollar / Spanish “Peseta” 
exchange rates to take into account time effects. 
Table 2 reports the variables’ descriptive statistics, and it shows the correlation matrix 
among variables. 
 
TABLE 2 ABOUT HERE 
 
4. Results 
4.1 Descriptive analysis 
Before discussing the results of the main econometric estimations, we present some 
descriptive statistics highlighting the different behavior and characteristics of firms that have 
entered the US market and those firms that have not. Table 3 compares firms in terms of 
patents and trademarks. Provided that trademarks signal an active commercial activity of 
the firms in the US market, one might hypothesize that those firms which have filed a 
trademark also show a higher innovative profile. Indeed, it seems reasonable to suppose 
that each trademark refers to a branded product, which is the outcome of an innovative 
activity whose results have been legally protected with a bundle of patents. However, Table 
3 seems to reveal that this line of reasoning is incorrect. Among those firms having filed a 
trademark, only one third owns at least one patent. Notice that we are comparing 
trademarks filed by Spanish companies in the US with patents filed by the same companies 
in the European Patent Office. If entering a foreign market may be considered an 
“exceptional” event, protecting innovations with patents filed in the “local” patent office 
should not be an “exceptional” activity, especially for Pharmaceutical firms whose innovative 
propensity is, on average, higher than that of firms belonging to different sectors. 
Nevertheless, in relative terms, Table 3 also shows that the patenting activity of firms with 
trademarks is higher than patenting activity of firms without trademarks (33.3% of firms 
with trademarks vs. 2.7% of firms without trademarks). 
 
TABLE 3 ABOUT HERE 
 
This evidence is similarly reported in Table 4, which compares the behavior of firms along 
several dimensions, and which illustrates how the two groups of firms do possess different 
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characteristics. Firms having entered the US market have patented more and have patented 
in a higher number of technological classes (i.e., they show a slightly higher degree of 
technological diversification – lower SCOPE_ECONOMIES). Furthermore, they seem to possess a 
cost advantage with respect to the other group (lower INV_EFFICIENCY), a higher profitability, 
and a slightly smaller size (even though the differences along these three dimensions are not 
significant from the statistical point of view). Finally, they are older (age, in this respect, 
might signal higher accumulated experience that turns out to be useful to enter a foreign 
market), belong to a group (similarly to age, this variable might account for accumulated 
corporate experience and complexity which might facilitate internationalization – though 
this variable is not significant), and have mainly chosen the public corporation legal form. In 
sum, it appears from Table 4 that firms that have entered the US market possess superior 
technological capabilities, a cost advantage, and higher accumulated experience. 
 
TABLE 4 ABOUT HERE 
 
4.2 Econometric analysis 
To test our hypotheses we have used a hazard model that estimates the hazard rate, namely 
the probability of entry into a market in year t, conditional on not being in the market at 
time t–1. Hazard models draw on hazard functions, which are distribution functions of the 
duration or spell length for a firm F(t) = Pr(T<t), where T is the duration. Hazard rates are 
estimated from hazard functions. They are the rates at which spells are completed at 
duration t, given that they have lasted until t, 
λ(t) = f(t)/S(t) 
where 
f(t) = dF(t)/dt 
is the number of firms that have entered the market at time t, while 
S(t) = 1−F(t) = Pr(T ≥ t) 
the set of firms whose duration is at least t, is the number of firms still at risk at time t, i.e. 
the risk set (Blossfeld and Rohwer, 2002). 
Following earlier works (Sorenson, 2000; Dobrev et al., 2002; Giarratana and Fosfuri, 
2007) on firm survival in industry population, we opted for a piecewise exponential model 
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specification that does not make any strong assumption on time dependence. Given the 
time periods, this model could be expressed as: 
Λjt = exp (α + Xjt βj) 
where X is the covariate vector, β is the vector of coefficients assumed not to vary across 
time and α is a constant coefficient associated with the t time period (see Blossfeld and 
Rohwer 2002: 120). 
 
Results 
Table 5 reports the results of our estimations. While Model 1 only contains control variables, 
from Model 2 to Model 6 we gradually include the core explanatory variables. In Model 7 we 
add an interactive term (SCOPE_ECONOMIES * INV_EFFICIENCY) between our measures of scope 
economies and cost efficiency, in order to assess how the interaction between the two 
dimensions affects firms’ behavior. 
Overall, our estimations provide support to most of our hypotheses. Indeed, as 
predicted by Hypothesis 1, TECH_CAPABILITIES is always positive and significant in all the 
specifications and, as predicted by Hypotheses 2 and 3, SCOPE_ECONOMIES and INV_EFFICIENCY 
are always negative. Note that both variables result significant only in Model 7, when 
including the multiplicative effect. This means that to fully capture the effect of different 
strategies, we need to consider their jointly effects. Therefore, it emerges that firms with 
stronger innovative capabilities, with a broader diversification of technological competences, 
and with a higher efficiency in manufacturing (i.e., firms that are able to reduce the average 
cost of production) show a higher probability of entering the US market. 
 
TABLE 5 ABOUT HERE 
 
Moreover, Model 7 reveals a counter-intuitive joint effect of scope economies and cost 
efficiency. Indeed, the interaction variable, which defines how one dimension attenuates or 
strengthens the effects of the other, has a significant positive impact on the entry 
probability.  
To interpret our findings better, we report in Table 6 the estimates of the multiplier rate 
of entry, conditional on different values of INV_EFFICIENCY and SCOPE_ECONOMIES. A multiplier 
rate of 1 means that a variable has no effect on the entry rate. A multiplier rate higher than 
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1 implies that a particular level of a variable increases the chances of entry. Table 6 explores 
the change in entry rate due to a more diversified patent portfolio for given levels of cost 
efficiency, and vice versa. Multiplier rates are computed with a baseline model of a firm with 
a median value of INV_EFFICIENCY (1.143) and of SCOPE_ECONOMIES (0.5): M = exp (– 10.621 * 
INV_EFFICIENCY – 14.125 * SCOPE_ECONOMIES + 10.451 * INV_EFFICIENCY * SCOPE_ECONOMIES) / exp 
(– 14.125 * 0.5 – 10.621 * 1.143 + 10.451 * 1.143 * 0.5). First, note that for all the levels of 
INV_EFFICIENCY except the one corresponding to the 90% of the distribution, increases in the 
value of SCOPE_ECONOMIES (i.e., decreasing the degree of patent diversification) decrease the 
hazard of entry. This finding confirms our second hypothesis. Similarly, for any value of 
SCOPE_ECONOMIES, increases in the value of INV_EFFICIENCY decrease the entry probability, 
which confirms our third hypothesis.  
Only for firms that have a worst performance in terms of cost efficiency (high levels of 
INV_EFFICIENCY), an increase in patent concentration increases the probability of entry. 
Therefore, this result captures the entry of firms with a high degree of technological 
specialization and with the lowest cost performance. This could be explained by a typical 
feature of the pharma industry in which some firms could attempt the entry with 
breakthrough innovative drugs or compounds that are the results of costly radical and 
specialized research (Gans and Stern, 2003). Figure 2 presents a graphical representation of 
this effect. 
 
TABLE 6 ABOUT HERE 
FIGURE 2 ABOUT HERE 
 
On the whole, Table 6 and Figure 2 seem to suggest that entry strategies based on the 
simultaneous exploitation of cost and technological diversification advantages are 
successful. Thus, hybrid strategies seem to prevail over pure competitive strategies. 
However, this effect is not linear.  If a firm faces high production costs, to concentrate the 
innovative activity on a narrow technological field is the only possibility to slightly enhance 
the entry probability. Notice, however, that the effect of SCOPE_ECONOMIES is definitely 
smaller than that of cost efficiency. Therefore, for very high levels of cost inefficiency, no 
patent concentration can completely compensate a cost disadvantage (the level of the 
multiplier remains below 1). Our conclusion is that the ambidexterity is a workable 
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hypothesis, except for firms with the worst cost efficiency that seems to lack this 
competency. 
As a robustness check, we replicate the same regression excluding from the sample 
those firms belonging to business groups having a US parent company and/or controlling a 
US subsidiary. Indeed, having a US subsidiary or being part of a US-based business group 
could be organizational substitutes for direct entry in the US market with branded products. 
Obtained results, available on request, are perfectly in line with those obtained in Model 7. 
 
 
5. Conclusions 
This study analyzes how the patenting and cost efficiency of a sample of Spanish 
pharmaceutical firms affect their internationalization process. We find that patent intensity, 
technological diversification and the level of a firm’s cost efficiency explain the entry in the 
US market with a branded product. Moreover, results show that below a certain threshold of 
productivity, a patent concentration strategy slightly compensates an inefficient cost 
strategy in the probability of entry. Nevertheless, the multiplier effect remains monotonic 
decreasing. 
These findings may help managers identify the key factors needed to elaborate effective 
international growth strategies. In an innovation-based sector like pharmaceuticals, strong 
technological capabilities are needed to structure the internationalization strategy as a long-
term success. A competitive strategy focused on scope economies, however, cannot be 
pursued at the expenses of the firm’s costs. The highest probability of entry a foreign market 
lies in the simultaneous exploitation of a benefit and a cost advantage. Thus, a hybrid 
strategy appears superior to a pure competitive strategy. But, hybrid strategies can 
effectively be pursued only by ambidextrous organizations that are able to mitigate the 
tensions of exploitation of current capabilities with exploration of new domains. 
Nevertheless, this result is not always confirmed. Very cost inefficient firms might result 
better off by concentrating their innovative activity on a limited technological area, maybe 
because this choice allows firms to invest their limited resources on just one activity 
(technology development), thus avoiding the risk of resources’ dispersion. 
Such results are specific to the sphere of the study (Spanish pharmaceutical firms 
entering the US market with branded products), and might differ if the industry or the home 
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country or the host country were to change. Yet, we partly confirm the results obtained by a 
previous study on the localization choices of Spanish MNEs (Galan et al., 2007), which shows 
that Spanish firms decide to enter into advanced countries both to exploit their firm-specific 
advantages, and to benefit of technologies, knowledge and capabilities that are not available 
in Spain. 
As far as empirical methodology is concerned, a related contribution of this study is 
about measurement. We explore the usefulness of a novel measure of foreign activity that is 
represented by trademarks. Being representative of entry in a foreign country with branded 
products, trademarks cover different entry modes, from export to FDIs. We believe that 
future research on small-to-medium sized international firms can then benefit from the use 
of this variable to overcome the lack of data on sales in foreign markets and related 
investments. 
Moving this research a step further, we are now in the process of understanding firm’s 
performances and trying to see if internationalization produces a positive effect on firms’ 
sales and profits. This raises both econometric complications and interesting strategic 
concerns that we will try and tackle in future research. 
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Table 1. Time distribution of entry 
Year 
# firms that 
not entered 
# firms that 
entered 
Total 
1995 503 4 507 
1996 500 3 503 
1997 498 2 500 
1998 497 1 498 
1999 494 3 497 
2000 492 2 494 
2001 492 0 492 
2002 489 3 492 
2003 489 0 489 
2004 486 3 489 
Total 4,940 21 4,961 
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Table 2. Variables’ descriptive statistics and correlation matrix 
  Mean Std. Dev. 1 2 3 4 5 6 7 8 9 10 11 12 
1. ENTRY 0.00 0.06 1.00            
2. TECH_CAPABILITIES 0.00 0.00 0.00 1.00           
3. SCOPE_ECONOMIES 0.99 0.07 -0.04 0.00 1.00          
4. INV_EFFICIENCY 2.05 9.13 -0.01 0.00 0.01 1.00         
5. FIXED_ASSET 5404.77 16986.92 0.01 -0.01 -0.29 -0.01 1.00        
6. ROA 4.87 31.16 0.01 -0.01 -0.02 -0.06 0.02 1.00       
7. AGE 19.64 16.82 0.03 -0.01 -0.15 -0.04 0.24 0.06 1.00      
8. CORPORATION 0.59 0.49 0.04 0.01 -0.08 0.01 0.14 0.09 0.31 1.00     
9. GROUP_98 0.26 0.44 0.01 -0.01 -0.16 0.00 0.26 0.12 0.14 0.21 1.00    
10. PARENT_US 0.00 0.06 -0.01 0.00 -0.17 -0.01 0.35 -0.01 -0.04 0.05 0.11 1.00   
11. SUBSIDIARY_US 0.03 0.18 -0.01 0.00 -0.07 0.05 0.13 0.00 0.06 -0.02 0.30 -0.01 1.00  
12. EXCHANGE_RATE 152.78 20.99 -0.02 -0.01 0.00 0.02 0.02 0.02 0.00 -0.08 -0.04 0.00 0.00 1.00 
 
 
 
 
Table 3. Comparison of patent and trademark activities among firms/years 
US EP Patents 
Trademarks No Yes Total 
No 4,665 275 4,940 
Yes 11 10 21 
Total 4,676 285 4,961 
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Table 4. Mean comparison of firms’ characteristics among firms/years 
 Entry 
Variable No Yes Difference 
0.056 0.476 -0.421 *** 
DUMMY_PATENT (0.003) (0.112) (0.051)  
0.192 2.762 -2.570 *** 
#  OF PATENTS (0.018) (1.259) (0.289)  
0.990 0.917 0.073 *** 
SCOPE_ECONOMIES (0.001) (0.039) (0.015)  
2.055 1.218 0.837  
INV_EFFICIENCY (0.157) (0.069) (2.221)  
5394.00 7632.17 -2238.17  
FIXED_ASSET (286.93) (2408.69) (4130.29)  
4.842 9.880 -5.038  
ROA (0.531) (2.075) (7.577)  
19.611 27.429 -7.818 ** 
AGE (0.239) (3.951) (3.677)  
0.261 0.381 -0.120  
GROUP_98 (0.006) (0.108) (0.096)  
0.590 0.905 -0.315 *** 
CORPORATION (0.007) (0.066) (0.107)   
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Table 5. Hazard Rates for Piecewise Exponential Model for Market Entry, 1995-2004 
Independent variables Model 1   Model 2   Model 3   Model 4   Model 5   Model 6   Model 7   
Control variables:               
FIXED_ASSET 0.000  0.000  0.000  0.000  0.000  0.000  0.000  
 (0.000)  (0.000)  (0.000)  (0.000)  (0.000)  (0.000)  (0.000)  
ROA 0.008  0.007  0.009  0.009  0.009  0.009  0.007  
 (0.008)  (0.010)  (0.008)  (0.008)  (0.009)  (0.010)  (0.010)  
AGE 0.017  0.016  0.017  0.015  0.015  0.014  0.013  
 (0.013)  (0.013)  (0.013)  (0.013)  (0.013)  (0.013)  (0.014)  
CORPORATION 1.804  1.794  1.876  1.803  1.866  1.873  1.923  
 (6.983)  (6.911)  (8.002)  (7.081)  (7.960)  (8.083)  (8.719)  
GROUP_98 -0.066  -0.081  -0.069  -0.188  -0.187  -0.190  -0.268  
 (0.550)  (0.540)  (0.552)  (0.565)  (0.567)  (0.562)    
EXCHANGE_RATE 3.590 ** 3.597 ** 3.574 ** 3.598 ** 3.585 ** 3.589 ** 3.585 ** 
 (16.524)  (16.660)  (16.810)  (16.625)  (16.880)  (16.991)  (16.883)  
YEAR DUMMIES Yes  Yes  Yes  Yes  Yes  Yes  Yes  
Explanatory variables:               
INV_EFFICIENCY   -0.190        -0.199  -10.621 * 
   (0.142)        (0.155)  (0.000)  
TECH_CAPABILITIES     413.574 **   400.414 ** 407.820 ** 406.130 ** 
     (6.3E+181)    (1.2E+176)  (2.0E+179)  (3.7E+178)  
SCOPE_ECONOMIES       -2.616  -2.501  -2.472  -14.125 * 
       (0.165)  (0.184)  (0.189)  (0.000)  
SCOPE_ECONOMIES * INV_EFFICIENCY             10.451 * 
             (158461.0)  
Number of observations 3477   3379   3370   3475   3368   3367   3367   
Log pseudoLikelihood 10.537   11.108   11.279   11.301   11.985   12.227   12.699   
†p<0.10, *p<0.05, **p<0.01. Heteroskedastic consistent standard errors in parentheses. 
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Table 6. Multiplier Rates for Entry 
  INV_EFFICIENCY 
  Min 10th cent 30th cent 50th cent 70th cent 90th cent 
SCOPE_ECONOMIES 0.003 0.941 1.042 1.143 1.315 2.046 
0.50 471.152 2.984 1.729 1.000 0.397 0.008 
0.60 115.045 1.942 1.251 0.805 0.382 0.016 
0.75 13.881 1.020 0.770 0.581 0.361 0.047 
0.90 1.675 0.536 0.474 0.419 0.340 0.140 
1.00 0.409 0.349 0.343 0.337 0.327 0.289 
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Figure 1. Entry strategies in foreign markets 
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Source: adapted from Terpstra and Sarathy (2001). 
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Figure 2. Multiplier Rates for Entry 
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